US drug authority approves new mRNA flu vaccine

TL;DR AI-generated The US Food and Drug Administration (FDA) has approved Moderna's mFlusiva, the first pure mRNA flu vaccine, for individuals over 50. A study showed a 27 percent reduction in flu cases among the vaccinated group.